{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:17:24Z","timestamp":1792739844388,"version":"4.5.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"8","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Genetic modification of clinical-grade T cells is undertaken to augment function, including redirecting specificity for desired antigen. We and others have introduced a chimeric antigen receptor (CAR) to enable T cells to recognize lineage-specific tumor antigen, such as CD19, and early-phase human trials are currently assessing safety and feasibility. However, a significant barrier to next-generation clinical studies is developing a suitable CAR expression vector capable of genetically modifying a broad population of T cells. Transduction of T cells is relatively efficient but it requires specialized manufacture of expensive clinical grade recombinant virus. Electrotransfer of naked DNA plasmid offers a cost-effective alternative approach, but the inefficiency of transgene integration mandates ex vivo selection under cytocidal concentrations of drug to enforce expression of selection genes to achieve clinically meaningful numbers of CAR+ T cells. We report a new approach to efficiently generating T cells with redirected specificity, introducing DNA plasmids from the Sleeping Beauty transposon\/transposase system to directly express a CD19-specific CAR in memory and effector T cells without drug selection. When coupled with numerical expansion on CD19+ artificial antigen-presenting cells, this gene transfer method results in rapid outgrowth of CD4+ and CD8+ T cells expressing CAR to redirect specificity for CD19+ tumor cells. [Cancer Res 2008;68(8):2961\u201371]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-5600","type":"journal-article","created":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T18:14:04Z","timestamp":1208283244000},"page":"2961-2971","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":218,"title":["Redirecting Specificity of T-Cell Populations For CD19 Using the <i>Sleeping Beauty<\/i> System"],"prefix":"10.1158","volume":"68","author":[{"given":"Harjeet","family":"Singh","sequence":"first","affiliation":[{"name":"1Pediatrics and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi R.","family":"Manuri","sequence":"additional","affiliation":[{"name":"1Pediatrics and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Olivares","sequence":"additional","affiliation":[{"name":"1Pediatrics and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Dara","sequence":"additional","affiliation":[{"name":"1Pediatrics and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret J.","family":"Dawson","sequence":"additional","affiliation":[{"name":"1Pediatrics and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Huls","sequence":"additional","affiliation":[{"name":"1Pediatrics and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry B.","family":"Hackett","sequence":"additional","affiliation":[{"name":"3Department of Genetics, Cell Biology and Development, University of Minnesota, St. Paul, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald B.","family":"Kohn","sequence":"additional","affiliation":[{"name":"4Division of Research Immunology\/Bone Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Shpall","sequence":"additional","affiliation":[{"name":"2Cancer Medicine, University of Texas M. D. Anderson Cancer Center, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Champlin","sequence":"additional","affiliation":[{"name":"2Cancer Medicine, University of Texas M. D. Anderson Cancer Center, Houston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence J.N.","family":"Cooper","sequence":"additional","affiliation":[{"name":"1Pediatrics and Divisions of"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,4,15]]},"reference":[{"key":"2022061700422947500_B1","doi-asserted-by":"crossref","unstructured":"Cooper LJ, Topp MS, Serrano LM, et al. T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect. Blood\u20082003; 101: 1637\u201344.","DOI":"10.1182\/blood-2002-07-1989"},{"key":"2022061700422947500_B2","doi-asserted-by":"crossref","unstructured":"Serrano LM, Pfeiffer T, Olivares S, et al. Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy. Blood\u20082006; 107: 2643\u201352.","DOI":"10.1182\/blood-2005-09-3904"},{"key":"2022061700422947500_B3","doi-asserted-by":"crossref","unstructured":"Jensen MC, Popplewell L, DiGiusto DL, et al. A first-n-human clinical trial of adoptive therapy using CD19-specific chimeric antigen receptor re-directed T cells for recurrent\/refractory follicular lymphoma. Mol Ther\u20082007; 15: S142.","DOI":"10.1016\/S1525-0016(16)44578-8"},{"key":"2022061700422947500_B4","doi-asserted-by":"crossref","unstructured":"Lupton SD, Brunton LL, Kalberg VA, Overell RW. Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol Cell Biol\u20081991; 11: 3374\u20138.","DOI":"10.1128\/mcb.11.6.3374-3378.1991"},{"key":"2022061700422947500_B5","doi-asserted-by":"crossref","unstructured":"Kowolik CM, Topp MS, Gonzalez S, et al. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells. Cancer Res\u20082006; 66: 10995\u20131004.","DOI":"10.1158\/0008-5472.CAN-06-0160"},{"key":"2022061700422947500_B6","doi-asserted-by":"crossref","unstructured":"Cid-Arregui A, Juarez V, zur Hausen H. A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J Virol\u20082003; 77: 4928\u201337.","DOI":"10.1128\/JVI.77.8.4928-4937.2003"},{"key":"2022061700422947500_B7","doi-asserted-by":"crossref","unstructured":"Patterson SS, Dionisi HM, Gupta RK, Sayler GS. Codon optimization of bacterial luciferase (lux) for expression in mammalian cells. J Ind Microbiol Biotechnol\u20082005; 32: 115\u201323.","DOI":"10.1007\/s10295-005-0211-8"},{"key":"2022061700422947500_B8","doi-asserted-by":"crossref","unstructured":"Berger C, Huang ML, Gough M, Greenberg PD, Riddell SR, Kiem HP. Nonmyeloablative immunosuppressive regimen prolongs in vivo persistence of gene-modified autologous T cells in a nonhuman primate model. J Virol\u20082001; 75: 799\u2013808.","DOI":"10.1128\/JVI.75.2.799-808.2001"},{"key":"2022061700422947500_B9","doi-asserted-by":"crossref","unstructured":"Jung D, Jaeger E, Cayeux S, et al. Strong immunogenic potential of a B7 retroviral expression vector: generation of HLA-B7-restricted CTL response against selectable marker genes. Hum Gene Ther\u20081998; 9: 53\u201362.","DOI":"10.1089\/hum.1998.9.1-53"},{"key":"2022061700422947500_B10","doi-asserted-by":"crossref","unstructured":"Ivics Z, Hackett PB, Plasterk RH, Izsvak Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell\u20081997; 91: 501\u201310.","DOI":"10.1016\/S0092-8674(00)80436-5"},{"key":"2022061700422947500_B11","doi-asserted-by":"crossref","unstructured":"Izsvak Z, Ivics Z. Sleeping beauty transposition: biology and applications for molecular therapy. Mol Ther\u20082004; 9: 147\u201356.","DOI":"10.1016\/j.ymthe.2003.11.009"},{"key":"2022061700422947500_B12","doi-asserted-by":"crossref","unstructured":"Geurts AM, Hackett CS, Bell JB, et al. Structure-based prediction of insertion-site preferences of transposons into chromosomes. Nucleic Acids Res\u20082006; 34: 2803\u201311.","DOI":"10.1093\/nar\/gkl301"},{"key":"2022061700422947500_B13","doi-asserted-by":"crossref","unstructured":"Huang X, Wilber AC, Bao L, et al. Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system. Blood\u20082006; 107: 483\u201391.","DOI":"10.1182\/blood-2005-05-2133"},{"key":"2022061700422947500_B14","doi-asserted-by":"crossref","unstructured":"Robbin PB, Yu XJ, Skelton DM, et al. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. J Virol\u20081997; 71: 9466\u201374.","DOI":"10.1128\/jvi.71.12.9466-9474.1997"},{"key":"2022061700422947500_B15","doi-asserted-by":"crossref","unstructured":"Holli RP, Nightingal SJ, Wan X, et al. Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon. Exp Hematol\u20082006; 34: 1333\u201343.","DOI":"10.1016\/j.exphem.2006.05.023"},{"key":"2022061700422947500_B16","doi-asserted-by":"crossref","unstructured":"Yan SR, Meus L, Chi W, Ivic Z, Izsva Z, Ka MA. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet\u20082000; 25: 35\u201341.","DOI":"10.1038\/75568"},{"key":"2022061700422947500_B17","doi-asserted-by":"crossref","unstructured":"Geurts AM, Yang Y, Clar KJ, et al. Gene transfer into genomes of human cells by the sleeping beauty transposon system. Mol Ther\u20082003; 8: 108\u201317.","DOI":"10.1016\/S1525-0016(03)00099-6"},{"key":"2022061700422947500_B18","doi-asserted-by":"crossref","unstructured":"Numbenjapon T, Serrano LM, Singh H, et al. Characterization of an artificial antigen-presenting cell to propagate cytolytic CD19-specific T cells. Leukemia\u20082006; 20: 1889\u201392.","DOI":"10.1038\/sj.leu.2404329"},{"key":"2022061700422947500_B19","doi-asserted-by":"crossref","unstructured":"Imai C, Iwamoto S, Campana D. Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. Blood\u20082005; 106: 376\u201383.","DOI":"10.1182\/blood-2004-12-4797"},{"key":"2022061700422947500_B20","doi-asserted-by":"crossref","unstructured":"Cooper LJ, Al-Kadhimi Z, Serrano LM, et al. Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1. Blood\u20082005; 105: 1622\u201331.","DOI":"10.1182\/blood-2004-03-1208"},{"key":"2022061700422947500_B21","unstructured":"Pathak S. Chromosome banding techniques. J Reprod Med\u20081976; 17: 25\u20138."},{"key":"2022061700422947500_B22","doi-asserted-by":"crossref","unstructured":"Scholten KB, Kramer D, Kueter EW, et al. Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells. Clin Immunol\u20082006; 119: 135\u201345.","DOI":"10.1016\/j.clim.2005.12.009"},{"key":"2022061700422947500_B23","doi-asserted-by":"crossref","unstructured":"Cooper LJ, Ausubel L, Gutierrez M, et al. Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma. Cytotherapy\u20082006; 8: 105\u201317.","DOI":"10.1080\/14653240600620176"},{"key":"2022061700422947500_B24","doi-asserted-by":"crossref","unstructured":"Jensen MC, Clarke P, Tan G, et al. Human T lymphocyte genetic modification with naked DNA. Mol Ther\u20082000; 1: 49\u201355.","DOI":"10.1006\/mthe.1999.0012"},{"key":"2022061700422947500_B25","doi-asserted-by":"crossref","unstructured":"Riddell SR, Greenberg PD. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J Immunol Methods\u20081990; 128: 189\u2013201.","DOI":"10.1016\/0022-1759(90)90210-M"},{"key":"2022061700422947500_B26","doi-asserted-by":"crossref","unstructured":"Gresch O, Engel FB, Nesic D, et al. New non-viral method for gene transfer into primary cells. Methods\u20082004; 33: 151\u201363.","DOI":"10.1016\/j.ymeth.2003.11.009"},{"key":"2022061700422947500_B27","doi-asserted-by":"crossref","unstructured":"Cui Z, Geurts AM, Liu G, Kaufman CD, Hackett PB. Structure-function analysis of the inverted terminal repeats of the sleeping beauty transposon. J Mol Biol\u20082002; 318: 1221\u201335.","DOI":"10.1016\/S0022-2836(02)00237-1"},{"key":"2022061700422947500_B28","doi-asserted-by":"crossref","unstructured":"Butler MO, Lee JS, Ansen S, et al. Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell. Clin Cancer Res\u20082007; 13: 1857\u201367.","DOI":"10.1158\/1078-0432.CCR-06-1905"},{"key":"2022061700422947500_B29","doi-asserted-by":"crossref","unstructured":"Suhoski MM, Golovina TN, Aqui NA, et al. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol Ther\u20082007; 15: 981\u20138.","DOI":"10.1038\/mt.sj.6300134"},{"key":"2022061700422947500_B30","doi-asserted-by":"crossref","unstructured":"Bachmann MF, Wolint P, Schwarz K, Jager P, Oxenius A. Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor \u03b1 and CD62L. J Immunol\u20082005; 175: 4686\u201396.","DOI":"10.4049\/jimmunol.175.7.4686"},{"key":"2022061700422947500_B31","doi-asserted-by":"crossref","unstructured":"Ochsenbein AF, Riddell SR, Brown M, et al. CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients. J Exp Med\u20082004; 200: 1407\u201317.","DOI":"10.1084\/jem.20040717"},{"key":"2022061700422947500_B32","doi-asserted-by":"crossref","unstructured":"Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature\u20081999; 401: 708\u201312.","DOI":"10.1038\/44385"},{"key":"2022061700422947500_B33","doi-asserted-by":"crossref","unstructured":"Baron V, Bouneaud C, Cumano A, et al. The repertoires of circulating human CD8(+) central and effector memory T cell subsets are largely distinct. Immunity\u20082003; 18: 193\u2013204.","DOI":"10.1016\/S1074-7613(03)00020-7"},{"key":"2022061700422947500_B34","doi-asserted-by":"crossref","unstructured":"Berger C, Jensen MC, Lansdorp PM, Gough M, Elliott C, Riddell SR. Adoptive transfer of effector CD8 T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest\u20082008; 118: 294\u2013305.","DOI":"10.1172\/JCI32103"},{"key":"2022061700422947500_B35","doi-asserted-by":"crossref","unstructured":"Park JR, Digiusto DL, Slovak M, et al. Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma. Mol Ther\u20082007; 15: 825\u201333.","DOI":"10.1038\/sj.mt.6300104"},{"key":"2022061700422947500_B36","doi-asserted-by":"crossref","unstructured":"Bell JB, Aronvovich EL, Schriefels JM, Clifford AM, Hoekstra ND, Whitley CB, Hackett PB. Duration of expression of Sleeping Beauty transposase in mouse liver following hydrodynamic delivery. Mol Ther 2006;13 Suppl 1:S150.","DOI":"10.1016\/j.ymthe.2006.08.453"},{"key":"2022061700422947500_B37","doi-asserted-by":"crossref","unstructured":"Sato T, Neschadim A, Konrad M, Fowler DH, Lavie A, Medin JA. Engineered human tmpk\/AZT as a novel enzyme\/prodrug axis for suicide gene therapy. Mol Ther\u20082007; 15: 962\u201370.","DOI":"10.1038\/mt.sj.6300122"},{"key":"2022061700422947500_B38","doi-asserted-by":"crossref","unstructured":"Yam P, Jensen M, Akkina R, et al. Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cells. Mol Ther\u20082006; 14: 236\u201344.","DOI":"10.1016\/j.ymthe.2006.02.017"},{"key":"2022061700422947500_B39","doi-asserted-by":"crossref","unstructured":"Wittnebel S, Da Rocha S, Giron-Michel J, et al. Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis. Cancer Res\u20082007; 67: 5594\u20139.","DOI":"10.1158\/0008-5472.CAN-06-4406"},{"key":"2022061700422947500_B40","doi-asserted-by":"crossref","unstructured":"Rooney CM, Smith CA, Ng CY, et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood\u20081998; 92: 1549\u201355.","DOI":"10.1182\/blood.V92.5.1549"},{"key":"2022061700422947500_B41","doi-asserted-by":"crossref","unstructured":"Powell DJ, Jr., Dudley ME, Robbins PF, Rosenberg SA. Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy. Blood\u20082005; 105: 241\u201350.","DOI":"10.1182\/blood-2004-06-2482"},{"key":"2022061700422947500_B42","doi-asserted-by":"crossref","unstructured":"Galkina E, Florey O, Zarbock A, et al. T lymphocyte rolling and recruitment into peripheral lymph nodes is regulated by a saturable density of L-selectin (CD62L). Eur J Immunol\u20082007; 37: 1243\u201353.","DOI":"10.1002\/eji.200636481"},{"key":"2022061700422947500_B43","doi-asserted-by":"crossref","unstructured":"Mitoma J, Bao X, Petryanik B, et al. Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment. Nat Immunol\u20082007; 8: 409\u201318.","DOI":"10.1038\/ni1442"},{"key":"2022061700422947500_B44","doi-asserted-by":"crossref","unstructured":"Bonini C, Bondanza A, Perna SK, et al. The suicide gene therapy challenge: how to improve a successful gene therapy approach. Mol Ther\u20082007; 15: 1248\u201352.","DOI":"10.1038\/sj.mt.6300190"},{"key":"2022061700422947500_B45","doi-asserted-by":"crossref","unstructured":"Ivics Z, Katzer A, Stuwe EE, Fiedler D, Knespel S, Izsvak Z. Targeted sleeping beauty transposition in human cells. Mol Ther\u20082007; 15: 1137\u201344.","DOI":"10.1038\/sj.mt.6300169"},{"key":"2022061700422947500_B46","doi-asserted-by":"crossref","unstructured":"Yant SR, Huang Y, Akache B, Kay MA. Site-directed transposon integration in human cells. Nucleic Acids Res\u20082007; 35: e50.","DOI":"10.1093\/nar\/gkm089"},{"key":"2022061700422947500_B47","doi-asserted-by":"crossref","unstructured":"Wilber A, Wangensteen KJ, Chen Y, et al. Messenger RNA as a source of transposase for Sleeping Beauty transposon-mediated correction of hereditary tyrosinemia type I. Mol Ther\u20082007; 15: 1280\u20137.","DOI":"10.1038\/sj.mt.6300160"},{"key":"2022061700422947500_B48","doi-asserted-by":"crossref","unstructured":"Morgan RA, Dudley ME, Wunderlich JR, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science\u20082006; 314: 126\u20139.","DOI":"10.1126\/science.1129003"},{"key":"2022061700422947500_B49","doi-asserted-by":"crossref","unstructured":"Kershaw MH, Westwood JA, Parker LL, et al. A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer. Clin Cancer Res\u20082006; 12: 6106\u201315.","DOI":"10.1158\/1078-0432.CCR-06-1183"},{"key":"2022061700422947500_B50","doi-asserted-by":"crossref","unstructured":"Lamers CH, Langeveld SC, Groot-van Ruijven CM, Debets R, Sleijfer S, Gratama JW. Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo. Cancer Immunol Immunother\u20082007; 56: 1875\u201383.","DOI":"10.1007\/s00262-007-0330-3"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/8\/2961\/2602546\/2961.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/8\/2961\/2602546\/2961.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T06:39:25Z","timestamp":1655447965000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/8\/2961\/543213\/Redirecting-Specificity-of-T-Cell-Populations-For"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,15]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2008,4,15]]},"published-print":{"date-parts":[[2008,4,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-5600","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,15]]}}}